Walgreens Boots Alliance. has been granted a patent for a system that provides drug pricing information through a graphical user interface. The system allows users to compare prices across multiple pharmacies, identify the lowest price, and determine potential savings without requiring a prescription. GlobalData’s report on Walgreens Boots Alliance gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Walgreens Boots Alliance, was a key innovation area identified from patents. Walgreens Boots Alliance's grant share as of June 2024 was 60%. Grant share is based on the ratio of number of grants to total number of patents.
Drug pricing information display system for pharmacies
The granted patent US12046337B1 outlines a server and method for providing drug pricing information to users through a graphical user interface (GUI) on electronic devices. The system is designed to receive electronic requests that include user identification, multiple pharmacy locations, and a specific prescription drug, while omitting detailed prescription information. The server transmits this information to a database management module, which accesses drug pricing data while ensuring that sensitive prescription details are not required for the initial request. The system then determines and compares drug prices across various pharmacies, identifies the location with the lowest price, and calculates potential savings for the user. This information is compiled into a notification that is sent back to the user's device for display.
Additionally, the patent specifies that the pharmacies involved may belong to a network and can be located within a single metropolitan area. The system is capable of comparing various pricing structures, including cash prices, co-pay prices, discount prices, and membership prices. The GUI can display comprehensive details such as pharmacy addresses, contact numbers, drug names, dosages, and potential savings. The technology is applicable to various electronic devices, including mobile phones, tablets, and laptops, enhancing accessibility for users seeking cost-effective medication options.
To know more about GlobalData’s detailed insights on Walgreens Boots Alliance, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.